340B Hospital Registration Waiver Withdrawal Could Draw Legal Challenge

Dept. of Health and Human Services building and signage
Hospital advocates said HRSA's recent decision to end a 340B program waiver for hospitals could draw legal challenges.
The recent end of a 340B program waiver for hospitals is wrong, hurts hospitals and their patients, and is bound [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Hospitals’ Community Benefit Surges in 2020, Says Hospital-Backed Report

AHA
The American Hospital Association published a study that found 340B hospitals' community benefit increased significantly in 2020.
The community benefits provided by 340B hospitals surged by $16.5 billion, or 24%, in the latest year analyzed by a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

HRSA To End Waiver for Some Offsite 340B Hospital Locations, Provides Grace Period

HRSA building and signage
HRSA confirmed it will end a pandemic-era waiver program that allowed 340B drug use in certain offsite hospital locations.
The Health Resources and Services Administration (HRSA) confirmed today it is ending a 340B program waiver issued early in the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Provider-Genentech Lobbying Group Boosts Spending, Adds Members

340B Working Table
More than 360 firms reported lobbying on the 340B program between July 1 and Sept. 30.
Genentech, Sanford Health, and Carolina Health Centers’ 340B reform group, 340B Working Table, spent $110,000 on lobbying and gained eight [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

GSK Adds Drug to Contract Pharmacy Restriction List

GSK headquarters
Senderra Rx will no longer dispense GlaxoSmithKline’s asthma drug, Nucala.
GlaxoSmithKline (GSK) recently restricted 340B pricing on Jesduvroq, an anemia treatment, when providers dispense it through contract pharmacies. GSK contractor [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Genentech Asks Hospitals to Check 340B Split-Billing Software Settings

Genentech building
Genentech gave advanced notice to 340B hospitals that the drugmaker would implement 340B contract pharmacy restrictions on May 1.
Drug manufacturer Genentech has asked health systems and hospitals about possible 340B program compliance violations involving split-billing software settings. Staff [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Teva Adds Drug to Hospital Contract Pharmacy Restriction Policy

Drugmaker Teva recently added its medication Austedo to its list of drugs under 340B contract pharmacy restrictions for hospitals.
Drug manufacturer Teva this week added a drug to the hospital contract pharmacy restrictions it first implemented in June. The [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

340B Dispute Resolution Final Rule Enters Last Stage of Regulatory Review

HHS signage and building
HRSA plans to host a webinar for federal grantees in the days leading up to the 2024 340B recertification period.
A final rule to implement the 340B administrative dispute resolution (ADR) process arrived this week at the last stage of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Rural Providers Urge Congress to Extend Pandemic-Era 340B Eligibility Exemptions

Tidelands Georgetown Memorial Hospital is part of a coalition of rural providers pushing Congress to extend a 2022 340B eligibility waiver.
More than 400 hospitals risk losing 340B eligibility if Congress does not extend exemptions authorized during the public health emergency [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Most 340B DSH Hospitals Provide Below-Average Charity Care, Says Analysis Backed by Critics

Bob Dold, a spokesperson for AIR340B, said the 340B program "has not translated into a stronger safety-net” after a drug industry backed analysis found 340B DSH hospitals provide below-average charity care.
The majority of 340B disproportionate share hospitals (DSH) provide charity care at lower rates than the national hospital average, found [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live